Changes in morphology of neuroblastoma cells treated with all-trans retinoic acid combined with transfer of the C-terminal region of the amyloid precursor protein

Journal of Clinical Laboratory Analysis

Volumn 12, Issue 3, 1998, Pages 172-178

  Honda, Saho ^a   Itoh, Fumio ^a   Yoshimoto, Mitsuru ^a   Hinoda, Yuji ^a   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

protein; All trans retinoic acid (ATRA); Alzheimer disease; Differentiation; Monoclonal antibody; Transfection

Indexed keywords

AMYLOID PRECURSOR PROTEIN; RETINOIC ACID;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROBLASTOMA CELL;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; BRAIN; CELL DIFFERENTIATION; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; TRANSFECTION; TRETINOIN; TUMOR CELLS, CULTURED;

ATRA;

EID: 0031970007     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1998)12:3<172::AID-JCLA8>3.0.CO;2-B     Document Type: Article

References (35)

1. Glenner GG, Wong CW: Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890, 1984.
2. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K: Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82:4245-4249, 1985.
3. Kang J, Lemaire HG, Unterbeck A, et al: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736, 1987.
4. Mullan M, Crawford F, Axelman K, et al.: A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat Genet 1:345-347, 1992.
5. Hendriks L, van Duijn CM, Cras P, et al.: Presenile dementia and cerebral haemorrhage linked to a mutation at cordon 692 of the β-amyloid precursor protein gene. Nat Genet 1:218-221, 1992.
6. Suzuki N, Cheung TT, Cai XD, et al.: An increased percentage of long amyloid β-protein secreted by familial amyloid β-protein precursor (βAPP717) mutants. Science 264:1336-1340, 1994.
7. Citron M, Vigo-Pelfrey C, Teplow DB, et al.: Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci USA 91:11993-11997, 1994.
8. Haass C, Hung AY, Selkoe DJ, Teplow DB: Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-amyloid protein precursor. J Biol Chem 269:17741-17748, 1994.
9. Hardy J: Alzheimer's disease: Clinical molecular genetics. Clin Geriatr Med 10:239-247, 1994.
10. Weidemann A, König G, Bunke D, Fischer P, Masters CL, Beyreuther K: Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57:115-126, 1989.
11. Saitoh T, Sundsmo M, Roch JM, et al.: Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts. Cell 58:615-622, 1989.
12. Milward EA, Papadopoulos R, Fuller SJ, et al.: The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neunte outgrowth. Neuron 9:129-137, 1992.
13. Moya KL, Benowitz LI, Schneider GE, Allinquant B: The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis. Dev Biol 161:597-603, 1994.
14. Kammesheidt A, Boyce FM, Spanoyannis AF, et al.: Deposition of β/ A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci U S A 89:10857-10861, 1992.
15. Fukuchi K, Kunkel DD, Schwartzkroin PA, et al.: Overexression of a C-terminal portion of the β-amyloid precursor protein in mouse brains by transplantation of transformed neuronal cells. Exp Neurol 127:253-264, 1994.
16. Shoji M, Golde TE, Ghiso J, et al.: Production of the Alzheimer amyloid β-protein by normal proteolytic processing. Science 258:126-129, 1992.
17. Nishimoto I, Okamoto T, Matsuura Y, et al.: Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). Nature 362:75-79, 1993.
18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
19. Saiki RK, Scharf S, Faloona F, et al.: Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354, 1985.
20. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74:5463-5467, 1977.
21. Chen C, Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752, 1987.
22. Saito N, Imai K: Immunological analysis of Alzheimer's disease using anti-β-protein monoclonal antibodies. Sapporo Med J 60:309-320, 1991.
23. Abemayor E, Sidell N: Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. Environ Health Perspecr 80:3-15, 1989.
24. Sidell N, Sarafian T, Kelly M, Tsuchida T, Haussler M: Retinoic acid-induced differentiation of human neuroblastoma: A cell variant system showing two distinct responses. Exp Cell Biol 54:287-300, 1986.
25. Seubert P, Oltersdorf T, Lee MG, et al.: Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 361:260-263, 1993.
26. Fraser PE, Levesque L, McLachlan DR: Alzheimer Aβ-amyloid forms an inhibitory neuronal substrate. J Neurochem 62: 1227-1230, 1994.
27. Jin LW, Ninomiya H, Roch JM, et al.: Peptides containing the RERMS sequence of amyloid-β/A4 protein precursor bind cell surface and promote neurite extension. J Neurosci 14:5461-5470, 1994.
28. Yankner BA, Duffy LK, Kirschner DA: Neurotrophic and neurotoxic effects of amyloid-β protein: Reversal by tachykinin neuropeptides. Science 250:279-282, 1990.
29. Kowall NW, Beal ME Busciglio J, Duffy LR, Yankner BA: An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance P. Proc Natl Acad Sci U S A 88:7247-7251, 1991.
30. 2+-channel hypothesis for neuronal death in Alzheimer's disease. Mol Cell Biochem 140:119-125, 1994.
31. Zhang C, Lambert MP, Bunch C, et al.: Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's Aβ peptide. J Biol Chem 269:25247-25250, 1994.
32. Kaneko I, Yamada N, Sakuraba Y, Kamenosono M, Tutumi S: Suppression of mitochondrial succinate dehydrogenase, a primary target of β-amyloid, and its derivative racemized at Ser residue. J Neurochem 65:2585-2593, 1995.
33. Strittmatter WJ, Weisgraber KH, Huang DY, et al.: Binding of human apolipoprotein E to synthetic amyloid-β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A 90:8098-8102, 1993.
34. s isoforms in PC12 cells: Relationsip to neunte outgrowth. Brain Res Dev Brain Res 88:30-36, 1995.
35. Yamatsuji T, Matsui T, Okamoto T, et al.: G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science 272:1349-1352, 1996.